Multiple Myeloma
Latest News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
Feature
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
Feature
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
Rare Diseases Report 2021
Meeting the unmet need in multiple myeloma
Conference Coverage
Isatuximab added to RVd boosts response in new myeloma
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.
News
FDA approves time-saving combo for r/r multiple myeloma
“The approval will help clinicians address unmet patient needs by reducing the administration time from hours to just minutes and reducing the...
From the Journals
Severe COVID two times higher for cancer patients
Roundtables
Treatment Sequencing in Relapsed/Refractory Multiple Myeloma
News
FDA warns of higher death risk with Pepaxto in multiple myeloma
The FDA also hinted at “a future public meeting to discuss the safety findings and explore the continued marketing of Pepaxto,” which has a price...
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
Feature
Cancer screening stopped by pandemic: Repercussions to come?